glp-1 drugs key developments 2025 Clinical Practice Updates: December Patients Face New Barriers for
Description
The oral segment is projected to witness the fastest CAGR from 2025 to 2032, driven by the growing demand for needle-free alternatives and the launch of oral GLP-1 receptor agonists such as Rybelsus (oral semaglutide) and future pipeline products such as orforglipron
The typical GLP-1 patch youll find online typically contains ingredients like green tea extract, garcinia cambogia, bitter orange extract, and vitamins
Long term outcomes of metabolic/bariatric surgery in adults
Compared to traditional injectable GLP-1 drugs, HS-10535's oral administration significantly improves patient adherence, which is crucial for enhancing the quality of life for diabetes patients
